Sponsor:
AHS Cancer Control Alberta
Code:
NCT04358913
Conditions
Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MR scan with the Alberta linac-MR P3 system
Brief summary:
Conditions
Cancer
Study ID
NCT04358913
Start date
Aug 23, 2021
Status verified date
May, 2025
Completion date
Jan, 2029
Anticipated
Primary completion date
Jan, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
250 participants
Anticipated
Intervention Model
Single group
Primary purpose
Device Feasibility
Arms
experimental: MR Imaging on the Alberta linac-MR P3 system
Interventions
MR scan with the Alberta linac-MR P3 system
Primary outcome measure
Central contacts
Locations
Cross Cancer Institute
Recruiting
Edmonton, Alberta, Canada, T6G 1Z2
Sponsor
AHS Cancer Control Alberta
Last update posted
May 14, 2025
Last verified
May, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by AHS Cancer Control Alberta on 2025-05-14.